Long lasting anti-hemophilia factor safe in kids, experts say

24 abril 2015

Children with hemophilia A require three to four infusions each week to prevent bleeding episodes, chronic pain and joint damage. A new, extended therapy combines recombinant factor VIII with a fusion protein that allows the molecule to remain in the circulation longer — translating into a need for less frequent treatment.